Sotera Health Co at JPMorgan Healthcare Conference Transcript
Thank you, everybody, for joining us today. I'm Casey Woodring from the life science tools and diagnostic team here at JPMorgan. I'm pleased to introduce Sotera Health CEO, Michael Petras. Michael is going to be doing a corporate presentation, then we're going to do a Q&A session afterwards. So with that, floor is yours.
Great. Thanks. Thanks, Casey. Thanks for having us here today. Before we begin, some of the statements I make today may be considered forward-looking statements. Please refer to our SEC filings for a description of the risks and uncertainties that could cause our actual results to materially be different from those implied or projected. The discussion will also talk about non-GAAP financial measures, including adjusted EBITDA, adjusted net income, adjusted EPS and net leverage. Please refer to our filings for reconciliation.
For some of you who may not be as familiar with the company.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |